Zoetis Inc (ZTS) Analysts See $0.63 EPS

October 7, 2017 - By Clifton Ray

 Zoetis Inc (ZTS) Analysts See $0.63 EPS
Investors sentiment decreased to 1.04 in 2017 Q2. Its down 0.20, from 1.24 in 2017Q1. It worsened, as 40 investors sold Zoetis Inc shares while 247 reduced holdings. 79 funds opened positions while 220 raised stakes. 444.27 million shares or 0.66% less from 447.23 million shares in 2017Q1 were reported.
Sentinel Asset Mgmt stated it has 575,000 shares or 0.87% of all its holdings. Daiwa Sb Ltd accumulated 0.16% or 9,456 shares. Gabelli Funds Ltd reported 687,059 shares or 0.25% of all its holdings. Old National Savings Bank In reported 25,879 shares or 0.09% of all its holdings. Panagora Asset Mgmt Inc holds 0.19% or 753,797 shares. Commonwealth Equity Ser Inc has 0.02% invested in Zoetis Inc (NYSE:ZTS) for 49,894 shares. Davenport Limited Liability Com has invested 0% of its portfolio in Zoetis Inc (NYSE:ZTS). Neuberger Berman Ltd Liability reported 4.56 million shares or 0.37% of all its holdings. New England And Management has invested 1.36% of its portfolio in Zoetis Inc (NYSE:ZTS). Braun Stacey owns 0.98% invested in Zoetis Inc (NYSE:ZTS) for 242,305 shares. Raymond James Na invested in 0.05% or 11,229 shares. Friess Associates Limited Liability Company stated it has 305,000 shares. Hanson Mcclain holds 0% of its portfolio in Zoetis Inc (NYSE:ZTS) for 333 shares. High Pointe Mngmt holds 1.27% or 13,170 shares. Gam Holding Ag holds 0.01% or 15,894 shares in its portfolio.

Analysts expect Zoetis Inc (NYSE:ZTS) to report $0.63 EPS on November, 1.They anticipate $0.11 EPS change or 21.15 % from last quarter’s $0.52 EPS. ZTS’s profit would be $308.13 million giving it 25.30 P/E if the $0.63 EPS is correct. After having $0.53 EPS previously, Zoetis Inc’s analysts see 18.87 % EPS growth. It closed at $63.75 lastly. It is up 29.89% since October 8, 2016 and is uptrending. It has outperformed by 13.19% the S&P500.

Zoetis Inc (NYSE:ZTS) Ratings Coverage

Among 19 analysts covering Zoetis Inc (NYSE:ZTS), 14 have Buy rating, 0 Sell and 5 Hold. Therefore 74% are positive. Zoetis Inc had 52 analyst reports since July 24, 2015 according to SRatingsIntel. On Friday, September 11 the stock rating was upgraded by BMO Capital Markets to “Outperform”. The stock of Zoetis Inc (NYSE:ZTS) earned “Hold” rating by Deutsche Bank on Wednesday, July 26. Craig Hallum maintained the stock with “Buy” rating in Wednesday, August 9 report. Piper Jaffray maintained Zoetis Inc (NYSE:ZTS) on Friday, August 25 with “Buy” rating. The rating was downgraded by BMO Capital Markets on Tuesday, June 13 to “Market Perform”. The rating was maintained by Cowen & Co with “Buy” on Monday, July 17. The firm has “Hold” rating given on Monday, August 7 by BMO Capital Markets. The stock of Zoetis Inc (NYSE:ZTS) earned “Buy” rating by Piper Jaffray on Friday, September 29. Goldman Sachs downgraded the shares of ZTS in report on Friday, May 6 to “Sell” rating. The firm has “Buy” rating by Cantor Fitzgerald given on Monday, August 14.

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company has market cap of $31.18 billion. The Firm has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It has a 36 P/E ratio. The Company’s divisions include the United States and International.

More recent Zoetis Inc (NYSE:ZTS) news were published by: Mlive.com which released: “Zoetis and Newell Brands receive tax breaks from city of Kalamazoo” on October 04, 2017. Also Mlive.com published the news titled: “Zoetis seeks Kalamazoo tax break for $64M manufacturing expansion” on September 19, 2017. Seekingalpha.com‘s news article titled: “Zoetis: Demanding Attention” with publication date: September 15, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com